Scarborough Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Scarborough Advisors’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13	Closed	-$277	–	468
2024 Q1	$277	Buy	+13	New	+$155	﹤0.01%	377

Scarborough Advisors's FUSN Position: Q2 2024 in Review

Scarborough Advisors sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 13 shares — an estimated $277 sold.

Scarborough Advisors first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $277 in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Scarborough Advisors reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Scarborough Advisors sold 13 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $277.
Scarborough Advisors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Scarborough Advisors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $277 in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Scarborough Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.